Interact to see
Advertisement
Advertisement
ADNRX vs FSMAX
ADNRX vs FSMAX Comparison
Open Charts ADNRX vs FSMAX
ADNRX vs FSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. FSMAX commentary
Jul 28, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and FSMAX is a Buy.
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 43.5B vs. ADNRX (138M). FSMAX pays higher dividends than ADNRX: FSMAX (0.48) vs ADNRX (0.00). ADNRX was incepted earlier than FSMAX: ADNRX (6 years) vs FSMAX (15 years). ADNRX (1.18) is less costly to investors than FSMAX (0.04). ADNRX is a more actively managed with annual turnover of: 46.00 vs. FSMAX (23.00). ADNRX (0) and FSMAX (0) have matching initial minimum investment requirements. FSMAX annual gain was more profitable for investors over the last year : 18.94 vs. ADNRX (-3.79). FSMAX return over 5 years is better than : 32.87 vs. ADNRX (-54.29).
| ADNRX | FSMAX | ADNRX / FSMAX | |
| Total Expense Ratio | 1.05 | 0.04 | 3,000% |
| Annual Report Gross Expense Ratio | 1.18 | 0.04 | 3,371% |
| Fund Existence | 6 years | 15 years | - |
| Gain YTD | -4.290 | 13.380 | -32% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 138M | 43.5B | 0% |
| Annual Yield % from dividends | 0.00 | 0.48 | - |
| Returns for 1 year | -3.79 | 18.94 | -20% |
| Returns for 3 years | 50.26 | 56.75 | 89% |
| Returns for 5 years | -54.29 | 32.87 | -165% |
| Returns for 10 years | N/A | 130.49 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers